Prostate cancer can have diverse effects on patients' quality of life (QoL). Standard QoL questionnaires do not address all of the concerns expressed by such patients. The primary purpose of this study was to identify those issues with the greatest influence on the QoL of patients with prostate cancer. A secondary aim was to compare the performance of the Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW) semi-structured interview with the Functional Assessment of Cancer Therapy-Prostate questionnaire (FACT-P). A mixed population of patients with prostate cancer (including those with localized and metastatic disease) completed the SEIQoL-DW and the FACT-P. The SEIQoL-DW was satisfactorily completed by 180 patients, including 93 patients with metastatic disease. Patients identified 144 separate QoL concerns, and these were then independently grouped by three of the authors into 13 distinct themes. The most frequently identified themes were 'leisure and hobbies', 'family' and 'health'. The themes that patients considered to be the most important were 'partner/spouse', 'family' and 'health'. Patients were most satisfied with their QoL in the domains of 'family', 'partner/spouse' and 'friends'. They were least satisfied with 'sexuality', 'mobility' and 'psychological factors'. Patients with metastatic disease rated their QoL significantly (Po0.0001) lower than other patients using the FACT-P, but not using the SEIQoL-DW (P ¼ 0.07). Patients with prostate cancer identified numerous QoL concerns that are not included (or are underrepresented) in standard health-related QoL questionnaires such as the FACT-P. Health-related QoL questionnaires may underestimate the QoL of patients with metastatic disease.
Introduction
Quality of life (QoL) is a difficult concept to define; nonetheless, the principle of measuring the impact of an illness/treatment on a patient's well-being rather than simply focusing on their survival or health status is now well accepted in healthcare research. 1 Dijkers 2 has categorized QoL assessment instruments on a continuum dependent upon the degree to which respondents are allowed to individualize their responses.
At one end of the continuum are those questionnaires in which respondents are presented with a predetermined set of QoL domains and are asked to rate their performance in each area. Most of the commonly used generic and disease-targeted instruments are found at this end of the continuum. ) contain items addressing four core areas (physical, psychological/ emotional, social and occupational well-being). * Disease-targeted instruments (for example, the Functional Assessment of Cancer Therapy-Prostate scale, FACT-P 5 ) supplement generic items with additional 'domains' specific to the group being investigated.
At the other end of the continuum are measures such as the Schedule for the Evaluation of Individual Quality of Life (SEIQoL) 6 that allow respondents to nominate significant QoL domains, rate their level of satisfaction and determine the relative weight of each domain. 7 The advantage of such instruments is that they do not impose a predetermined set of priorities on the respondent and they thus allow individuals to elaborate QoL in their own terms.
These contrasting approaches are likely to produce different insights into the impact of a disease or treatment on an individual patient's QoL. Prostate cancer is a good example of a disease process where one might expect significant discrepancies between instruments from opposite ends of the continuum. The purpose of this study was to compare QoL in patients with prostate cancer using an individualized assessment method (the Schedule for Evaluation of Individual Quality of LifeDirect Weighting, SEIQoL-DW) and a disease-targeted questionnaire (the FACT-P). Very few previous studies (involving only small numbers of patients) have reported experience with using SEIQoL-DW in patients with prostate cancer [8] [9] [10] and therefore little is known about the individual QoL concerns of these patients. No studies have directly compared the performance of SEIQoL-DW with health-related QoL questionnaires in this population.
Patients and methods
This was a prospective, observational study. The study protocol was approved by the Wandsworth Local Research Ethics Committee and received Research and Development approval from St George's Healthcare NHS Trust.
Patients
A convenience sample of patients with prostate cancer was recruited from the uro-oncology outpatient department at St George's Hospital and from Trinity Hospice, London, UK. To be eligible for the study, patients had to have a proven diagnosis of prostate cancer, sufficient English language skills to participate in a semi-structured interview and be able to give written informed consent.
Assessments
Patients were asked to complete the following instruments.
Schedule for the Evaluation of Individual Quality of LifeDirect Weighting (SEIQoL-DW) method. This is a semistructured interview in three parts. 11, 12 Cue elicitation. Patients are asked to nominate the five areas of their lives that they consider to be the most important. If patients are unable to nominate five areas spontaneously then they are prompted using a list of the domains most commonly nominated by other patients. 13 Cue scoring. Patients are then asked to score how well they are currently performing in each of these areas using a 0-100 mm vertical visual analogue scale (VAS). The VAS is anchored at either end by the verbal descriptors 'worst possible' and 'best possible'. Cue weighting. Patients are finally asked to weight the relative importance of each of these domains using a pie chart. The domains are listed on each of five overlapping rotating discs. The patients is then asked to adjust the position of the discs such that the relative size of each 'slice' represents the relative importance that the patient accords to each QoL 'domain'.
A 'global' QoL score for each patient can be obtained by multiplying the score on each domain by the relative weighting ascribed to it, and then summing the five scores. Scores thus obtained can range between 0 (representing 'worst' QoL) and 100 (representing 'best' QoL). A stylized example of a typical interview is shown in Figures 1 and 2 . It can be seen that he perceived that he was performing best in relation to his spiritual life and most poorly with respect to his work (cue scoring). However, he felt that spirituality was the least important of his chosen five QoL domains (only receiving 10% of the possible 'pie'), and that 'health' was the most important domain (Figure 2 -cue weighting). His global QoL can be calculated by summing the total of his 'weighted' cue scores:
Family 20%
Hobbies 20%
Health 35% Spirituality 10% Work 15% Figure 2 Cue weights for a 'representative' patient. The results of a SEIQoL-DW interview with a 'typical' hypothetical subject are shown. This individual listed 'family', 'hobbies', 'health', 'spirituality' and 'work' as his five most important quality-of-life (QoL) domains (cue elicitation). His scores for each domain are shown in the bar diagram ( Figure 1 ). It can be seen that he perceived that he was performing best in relation to his spiritual life and most poorly with respect to his work (cue scoring). However, he felt that spirituality was the least important of his chosen five QoL domains (only receiving 10% of the possible 'pie'), and that 'health' was the most important domain (cue weighting). His global QoL can be calculated by summing the total of his 'weighted' cue scores:
Quality of life in prostate cancer PC Stone et al domains; 'physical well-being', 'social/family wellbeing', 'emotional well-being', 'functional well-being' and 'additional concerns' (consisting of items relating specifically to prostate cancer and/or its treatment). Each item can be answered on a 5-point (0-4) scale. Scores for the whole questionnaire can range between 0 and 156. A subscale score can be generated for each domain. The sum of the scores on the first four domains constitutes the FACT-G (General). The sum of the scores on all five domains constitutes the FACT-P. For ease of presentation and for comparison with other QoL measures the FACT-P scores were linearly transformed onto a 0-100 scale with 0 representing worst QoL (that is, 0 of 156) and 100 representing best QoL (that is, 156 of 156).
Visual analogue scale. Subjects were asked to mark the point on a 100-mm horizontal line that best represented their global QoL. The anchor descriptors were 'worst possible' at 0 mm and 'best possible' at 100 mm.
Other assessments. Patients' Eastern Co-operative Oncology Group (ECOG) performance status (PS, 0-4; with 0 representing an ambulant patient and 4 representing a bed-bound patient requiring full nursing care) was recorded. A note was made of the time taken to complete each instrument.
Repeat assessments. Patients who returned to the clinic within the time frame of the study were asked to undergo repeat assessments with both the SEIQoL-DW and the FACT-P to assess the sensitivity of each instrument to changes in condition over time.
Statistical methods
Data were summarized using means and standard deviations. Comparisons between patients were made using unpaired t-tests; within-group comparisons were analysed using paired t-tests. For comparison of proportions w 2 -tests were used. With an estimated accrual of 150 patients the study had 90% power to detect a correlation of 0.45 or greater within in any subgroup (n ¼ 50) or of 0.3 or greater within the whole study population (n ¼ 150). The study had 90% power to detect a 7-point difference in SEIQoL-DW scores between subgroups (n ¼ 50).
Results
Patients attending the St George's Hospital uro-oncology outpatient department (n ¼ 587) or Trinity Hospice (n ¼ 75) were screened for inclusion in the study. A total of 303 patients were considered eligible to participate in the study and 197 (65%) gave written informed consent. Three of the patients were subsequently excluded from the analysis as they were found to have other urological malignancies but not prostate cancer. A total of 900 responses were generated and from this patients identified 144 distinct QoL concerns. Two of the authors (HEM and MQA) independently coded these concerns into broader themes. Any disagreement in theme allocation was resolved by a third author (PS). All identified concerns were finally coded by the three authors into 13 common themes (Table 2) . Seven cues remained unclassified and are represented in the Table as 'others'. The most frequently nominated themes were 'leisure and hobbies', 'family' and 'health', and the least frequently nominated themes were 'financial status', 'sexuality' and 'psychological factors'. However, when patients were asked to weight the relative importance that they attached to each domain, the order of priorities changed. The QoL domains that were perceived to be most important were 'partner/spouse', 'family' and 'health' and the domains that were perceived to be the least important were 'financial status', 'social life' and 'leisure and hobbies'. In terms of current satisfaction (cue scores) the patients were most satisfied with 'family', 'partner/spouse' and 'friends' and least satisfied with 'psychological factors', 'mobility' and 'sexuality'. There were no significant differences in the frequency with which themes were identified by patients with metastatic or locoregional disease or in the mean SEIQoL-DW scores (Table 3) . 
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Health-related quality of life: FACT-P FACT-P scores were available for 188 patients (Table 3) . The mean time to complete the FACT-P was 13.8 (s.d. 6.8) min. Patients scored significantly higher on the 'physical', 'social' and 'emotional' domains than on the 'functional' and 'additional concerns' domains (paired t-tests all o0.001). Patients with metastatic disease scored significantly lower on all QoL domains except 'social well-being'. Total FACT-G and FACT-P scores were also significantly different between the two groups.
Visual analogue scale
There was a significant difference between the VAS scores of patients with locoregional and metastatic disease (Table 3) .
Differences between first and second assessments
Some patients (n ¼ 96) proceeded to a second assessment, but paired data from both SEIQoL-DW and FACT-P were only available for 91. The mean age of these patients was 71 years (s.d. 8), 37 of 91 (41%) had metastatic disease and the majority had a good PS (0, n ¼ 39, 43%; PS 1, n ¼ 31, 34%; PS 2, n ¼ 13, 14%; PS 3, n ¼ 1, 1%; PS 4, n ¼ 0, 0%; not recorded, n ¼ 8, 9%). The second assessments occurred a mean of 22 (s.d. 10.9) weeks later. There were no significant changes in any of the QoL measures between the two assessments.
To determine the sensitivity to change of the various QoL measures, patients were asked whether they felt that their overall QoL had changed between the two assessments. The majority of patients (41 of 91, 45%) reported that their QoL was the 'same', 30 of 91 (33%) reported that it was 'worse' and 8 of 91 (9%) reported that it was 'better' (data missing on 12 patients). The relationship between patients' global perception of 'change in QoL' and the actual change in QoL scores is shown in Figure 3 . Patients who rated their global QoL 'worse' showed a statistically significantly reduction in FACT-P scores (P ¼ 0.038). None of the other changes in QoL measures were significantly different.
Performance status decreased in 28 of 91 patients (29%), remained the same in 35 of 91 (38%) and improved in 17 of 91 (19%), paired data were missing for 11 patients (Figure 4) . Patients in whom the PS deteriorated between assessments showed a statistically significant reduction in SEIQoL-DW (P ¼ 0.008) and VAS (P ¼ 0.05) but not FACT-P (P ¼ 0.08). Patients in whom the PS improved between assessments also reported significant improvements in QoL as measured by the VAS (P ¼ 0.005) but not with the SEIQoL-DW (P ¼ 0.3) or the FACT-P (P ¼ 0.5).
Discussion
Relatively few studies have investigated QoL in prostate cancer patients using SEIQoL-DW. Waldron et al. 8 described the use of SEIQoL-DW in 80 patients with advanced cancer (of whom 11% had prostate cancer). The most commonly nominated cues were 'family', 'health', 'social life', 'spiritual life' and 'friendships'. Willener and Hantikainen 9 administered the SEIQoL-DW to 11 men who had undergone a radical prostatectomy 3-4 months previously. The cues most frequently nominated by these patients were 'health', 'activity', 'family', 'relationship with a partner' and 'autonomy'. Broadhead 10 investigated QoL in 15 patients with early-stage prostate cancer using a similar individualized QoL assessment instrument (SEIQoL). The SEIQoL differs from the SEIQoL-DW in that weights are assigned to cues using 'judgement analysis' rather than by the direct-weighting method. The most frequently nominated cues in this study were 'family', 'health', 'finances', 'leisure/hobbies' and 'marriage'. Quality of life in prostate cancer PC Stone et al Our own study is by far the largest attempt to gauge individualized QoL in patients with prostate cancer. In keeping with previous studies we found that 'family' and 'health' are two of the most frequently nominated cues. However, rather than simply considering the frequency with which cues were nominated it is Patients whose performance status deteriorated (n = 28) * P < 0.05, ** P < 0.01 for change from baseline Figure 4 Change in quality-of-life (QoL) scores (effect size) related to change in performance status.
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PC Stone et al instructive to look at the relative weighting that such cues are given. Thus, although 'partner/spouse' was only nominated as a cue on 41 occasions, it was given the highest average 'weighting' of all of the nominated domains (35%). In contrast, although 'social life' was frequently nominated as a cue, it was given a low mean weighting (13.6%) with only 'leisure and hobbies' being given a lower weighting (13.2%). Some of the areas that were nominated as being among the five most important contributors to QoL during the SEIQoL-DW interview are not covered by any of the items in the FACT-P. For instance, 'spiritual life' was identified as an important contributor to QoL on 58 occasions and was given an average 'weighting' greater than sexuality, work, leisure activities and many other domains. Other areas of QoL seem to be overrepresented by items on the FACT-P. Thus, the FACT-P devotes 6 of 39 items to emotional well-being although 'psychological factors' were only nominated as an important contributor to QoL on 22 of 945 occasions during the SEIQoL-DW interviews and were given an average weighting of only 17.2%. The data relating to individualized assessment of sexuality require particular comment. The FACT-P contains three items concerning sexuality ('I am satisfied with my sex life', 'I am able to feel like a man' and 'I am able to have and maintain an erection'). However, in only 27 of 180 SEIQoL-DW interviews did men identify areas relating to sexuality as being one of their main concerns. Those men who did mention sexuality were clearly experiencing problems in this domain as signified by the low satisfaction scores (mean cue score ¼ 39.7). Indeed, satisfaction scores for sexuality were the lowest of all of the 13 QoL domains identified. However, these same men considered sexual issues to be 'relatively' unimportant compared to other QoL domains, with a mean weighting of only 17.8%. This is possibly an example of 'response shift' 14 whereby patients re-prioritize those areas that they consider to be most important as their illness progresses. Further longitudinal studies of individual QoL before, during and after anti-cancer therapy would help to investigate whether this is in fact what is occurring.
The FACT-P has been well validated and has demonstrated good internal consistency and reliability. 5, 15 Previous studies have used the FACT-P to evaluate QoL in patients with prostate cancer undergoing external beam radiotherapy, 16 brachytherapy, 16, 17 surgery, 16 cryosurgery, 18 ,19 chemotherapy 20 and treatment with an epidermal growth factor receptor inhibitor. 21 These studies have reported significant changes in health-related QoL in response to the various anti-cancer treatments.
In the original validation study of the FACT-P 5 sensitivity to change was deemed to be acceptable by comparing patients in whom PS deteriorated with those in whom PS improved. Subsequent studies have also confirmed that the FACT-P is able to detect significant changes in QoL. 16, 17, 19 In our own study we found that the FACT-P values did not significantly change in patients in whom the PS deteriorated. In contrast there were significant changes in SEIQoL-DW and VAS scores. However, the FACT-P was better at detecting deteriorations in 'global QoL' than either the SEIQoL-DW or the VAS.
Our study had a number of limitations. Due to practical and resource constraints we recruited a convenience sample of patients. This means that our study population was not necessarily representative of patients with prostate cancer more generally. However, the primary purpose of this study was not to determine the QoL of patients with prostate cancer per se but rather was to compare the attributes of different QoL assessment instruments among respondents with this disease. For this more modest aim, it was not necessary to have a consecutive series of patients. Our study would, however, have been strengthened by the inclusion of a reference group of age-matched men without cancer so that the ability of the different instruments to distinguish between the QoL of subjects with and without disease could be established. It would also have been informative to include subjects before and after specific interventions likely to alter QoL (for example, chemotherapy, radiotherapy or hormone therapy) to better assess the ability of the instruments to respond to expected changes in QoL.
In this study we have compared the QoL of patients with prostate cancer using the SEIQoL-DW and the FACT-P. Each approach has its advantages and disadvantages-employing both methods could potentially provide investigators with a rich data source that would be considerably more informative than either approach taken in isolation.
